What Western Diagnostic Pathology does

Western Diagnostic Pathology (WDP) is a clinical pathology diagnostic services provider operating across Western Australia and the Northern Territory as a trading brand of Healius Pathology Pty Ltd, a wholly-owned subsidiary of ASX-listed Healius Ltd. WDP runs 200+ collection sites and 10 laboratories (8 hospital-based in WA, 2 in NT) with 1,000+ staff including pathologists, scientists, collectors, couriers, and operations personnel, and is backed by access to the broader Healius national network of 2,000+ collection centres and reference laboratories offering more than 2,000 tests.

The technology stack is centred on the Medway platform, comprising Medway Results (real-time clinician results access), Medway Practice (consumables ordering, courier requests, appointments), eReferrals, Telehealth, and the Medway Clinical Trials Portal, complemented by the proprietary Healius MQLink EDI software that integrates WDP results directly into referring doctors' clinical software via PIT and HL7 standards. The product portfolio spans routine and specialised pathology testing, drug and alcohol testing (AS/NZS 4308 and 4760 accredited), employee wellness screening, biological monitoring, iron infusion procedures, non-invasive prenatal testing, and Phase I-IV clinical trial services delivered in partnership with Agilex Biolabs.

WDP operates a sales-led go-to-market primarily through healthcare provider referrals, supplemented by direct B2B sales for commercial services and a growing direct-to-consumer layer via online booking. Revenue is generated from Medicare bulk-billed MBS-covered tests, out-of-pocket payments for non-Medicare and specialised tests, transaction-fee commercial drug and alcohol testing, and professional services for clinical trial sponsors. The business holds NATA, ISO 15189, ISO 17025, TGA, and Australian Standard drug-testing accreditations, which together with its physical footprint and 50-year operating history in WA/NT form the foundation of its competitive position.

Name

Western Diagnostic Pathology

Legal name

Laverty Pathology Pty Ltd

Website

https://wdp.com.au

Company type

Private

Founded year

1972

Operating status

Operating

Headcount range

251–500 employees

Short description

Western Diagnostic Pathology provides clinical pathology diagnostic services across Western Australia and Northern Territory, operating 200+ collection centres and 10 laboratories as part of the Healius national network. It serves patients via clinician referrals, employers via workplace testing, and pharmaceutical sponsors through clinical trial services.

Ownership category

akta.pro rank

Product category

Diagnostic Pathology Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151), Medical and Diagnostic Laboratories (6215)

SIC

Services-Medical Laboratories (8071), Services-Health Services (8000)

akta.pro primary industry

Central Laboratory Services (Core Lab Operations) (HLAGAEAA)

akta.pro secondary industries

Anatomic Pathology (Histopathology & Cytopathology) (HLAFAMAA), Independent Diagnostic Testing Facilities (IDTFs) & Multi-Specialty Diagnostic Centers (HLAFAKAN), Pathology Reporting, Synoptic Templates & Cancer Registry Interfaces (HLACAMAJ)

Keywords

• Clinical pathology services
• Diagnostic laboratory testing
• Pathology collection centres
• Workplace drug testing
• Clinical trial laboratory

Headquarters

HQ city

Mareeba

HQ country

Australia

HQ region

Oceania

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Patient Pathology Testing Services: Core pathology diagnostic testing services billed to patients. Bulk bills Medicare-eligible tests covered under the Medicare Benefits Schedule (MBS). Out-of-pocket payments apply for tests not covered by Medicare, private billing requests, insurance/employment/immigration testing, and specialized tests.
2. Commercial Drug & Alcohol Testing: Workplace drug and alcohol testing programs for employers including urine, oral fluid, and hair testing. Accredited to AS4308 and AS4760 standards. Includes chain of custody consumables and policy assistance.
3. Employee Wellness & Occupational Health: Pre-employment health checks, wellness screening programs, and occupational risk testing for corporate clients. Includes cholesterol checks, glucose testing, liver function tests, thyroid testing, and PSA screening.
4. Clinical Trial Laboratory Services: Comprehensive lab services for pharmaceutical, biotech, and research organizations supporting clinical trials (Phases I-IV). Includes testing, logistics, data management, and specialized bioanalytical services through partnership with Agilex Biolabs.

Pricing tiers

Go-to-market motion1 record

Distribution channels6 records

Marketing channels5 records

Core offering

Western Diagnostic Pathology is a pathology diagnostic services provider operating collection centres and laboratories across Western Australia and Northern Territory. It delivers routine and specialised pathology testing (blood, tissue, cytology, infectious disease, genetic/molecular) for patients referred by clinicians, accredited workplace drug & alcohol testing and employee wellness screening for commercial clients, and NATA/ISO-accredited laboratory services supporting pharmaceutical and biotech clinical trials.

Product overview

Western Diagnostic Pathology (WDP) operates as part of the Healius Pathology national network, providing comprehensive pathology diagnostic services across Western Australia and Northern Territory. The core offering centers on clinical pathology testing services (blood tests, tissue pathology, cytology, infectious disease testing, genetic/molecular testing) delivered through a network of over 230 collection sites and 10 laboratories. Patient-facing services include the online booking system and mobile collections. The clinician-facing portfolio includes the Medway Results Portal (real-time results access) and Medway Practice portal (consumables ordering, courier management), complemented by eReferrals and Telehealth modules. The commercial/occupational health division offers Drug & Alcohol Testing, Employee Wellness Screening, Biological Monitoring Testing, and Clinical Trials Services. Technology infrastructure includes the proprietary Healius MQLink EDI software for clinical system integration and Medway Clinical Trials Portal for research workflows. Additional specialized services include Iron Infusion Clinic, Generation NIPT prenatal testing, and clinical publications such as Diabetes Watch 2025.

Differentiator

Problem solved

Functional benefit

Products and services

• Medway Results Portal

Quantifiable outcome

• 70% of medical decisions rely on pathology results
• +2 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability2 records

Feature3 records

Partnerships

One partnership is on record.

• Agilex BiolabscoreStrategic or Co-development PartnerAgilex Biolabs provides specialized bioanalytical testing services with FDA-inspected facilities for clinical trials. WDP partners with Agilex to offer comprehensive clinical trial services including advanced bioanalytical testing capabilities for pharmaceutical and biotech clients conducting Phase I-IV trials.

Scale indicators8 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Sonic Healthcare: Sonic Healthcare is the largest pathology provider in Australia and operates a national network of collection centres and labs (Sullivan Nicolaides, Douglass Hanly Moir, Clinipath, etc.). It directly competes with WDP for patient testing, workplace drug screening, and clinical trial services across Australia, including WA.
• Australian Clinical Labs: Australian Clinical Labs is a national ASX-listed pathology operator with a broad test menu and significant WA presence following the 2022 ACL/Clinipath integration. It competes head-to-head with WDP on patient testing, occupational health, and clinical trial services in Western Australia.
• Sullivan Nicolaides Pathology: Sullivan Nicolaides Pathology is a Sonic Healthcare-owned laboratory that provides comprehensive pathology services in Queensland and northern NSW and competes for clinical trial and occupational health work. It is comparable in service breadth and clinician-integrated workflow approach to WDP.

Broad incumbents

• Healius Ltd: Healius Ltd is the ASX-listed parent of WDP and other pathology brands (Laverty, Dorevitch, QML, Abbott, TML). It is the broader incumbent whose corporate strategy and capital allocation directly govern WDP's investment and growth profile.
• Laverty Pathology: Laverty Pathology is a sibling Healius brand operating in NSW and ACT, offering the same Medway platform and similar service mix as WDP. It is directly comparable in business model and digital infrastructure but serves a different geography.
• Dorevitch Pathology: Dorevitch Pathology is a Healius-owned pathology brand serving Victoria. It shares the same Medway platform and operational backbone as WDP, making it a direct operational comparable for unit economics, digital integration, and clinician workflow.

Regional players

• PathWest Laboratory Medicine WA: PathWest is the WA public-sector pathology provider operating from public hospital laboratories. It competes with WDP for hospital-based testing contracts and specialist referrals across Western Australia, though its public-sector mandate and funding model differ.

Emerging players

• Agilex Biolabs: Agilex Biolabs is a specialised bioanalytical laboratory that partners with WDP on clinical trial services. It is comparable as a regulated, NATA/ISO-accredited lab serving pharmaceutical and biotech clients, and reflects a peer capability that competes for similar pharma outsourced work.
• 4DMedical: 4DMedical is an ASX-listed medical technology company focused on respiratory imaging diagnostics. While it operates in a different sub-modality, it is a comparable Australian-listed diagnostics business pursuing hospital and clinical integration channels that overlap with WDP's clinician engagement.
• Genomic Diagnostics (Healius): Genomic Diagnostics is a Healius-affiliated specialty genetics laboratory that provides molecular and cytogenetic testing. It is comparable to WDP's Generation NIPT and genetic pathology capability and competes in the same specialised molecular diagnostics segment.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks1 record

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/western-diagnostic-pathology

Compliance8 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Western Diagnostic Pathology